Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
targets cardiorenal syndrome in LVAD patients
CMOs charge 15-30% premiums amid <12% gene-therapy plant vacancy (2025)
This constant evolution ensures the platform meets user needs and stays competitive
marking a significant development
FY25 ARR $210M (reporting ≈$37
BIORA THERAPEUTICS PORTER'S FIVE FORCES TEMPLATE RESEARCH B_64 targets cardiorenal syndrome in LVADWhat is included in the product Detailed Word Document Analyzes the competitive landscape, pinpointing threats and opportunities for Biora Therapeutics. Customizable Excel Spreadsheet Customize pressure levels based on new data or evolving market trends. Preview Before You Purchase Biora Therapeutics Porter's Five Forces Analysis The displayed Biora Therapeutics Porter's Five Forces analysis is the full, ready to use report. This preview provides the
US$ 19.99
US$ 44.95
US$ 58.95
US$ 16.99
US$ 16.99
